Publications by authors named "Shruti Parulekar"

Background: Our near-real-time safety monitoring of 16 adverse events (AEs) following COVID-19 mRNA vaccination identified potential elevation in risk for six AEs following primary series and monovalent booster dose administration. The crude association with AEs does not imply causality. Accordingly, we conducted robust evaluation of potential associations.

View Article and Find Full Text PDF
Article Synopsis
  • Guillain-Barré syndrome (GBS) is a rare neurological condition that may occur after vaccination, prompting this study to investigate its risk following the recombinant zoster vaccine (RZV or Shingrix).
  • The study analyzed Medicare claims data from over 2 million beneficiaries aged 65 and older to compare the risk of GBS between those vaccinated with RZV and those with the live zoster vaccine (ZVL or Zostavax).
  • Results indicated that there is an increased risk of GBS in RZV vaccinees compared to ZVL vaccinees, with a rate ratio of 2.34, suggesting a significant difference in risk between the two vaccines.
View Article and Find Full Text PDF

Importance: Previous studies have found that the risk of severe hypoglycemia does not differ between long-acting insulin analogs and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes. However, these studies did not focus on patients 65 years or older, who are at an increased risk for hypoglycemia, or did not include patients with concomitant prandial insulin use.

Objective: To examine the risk of emergency department (ED) visits or hospitalizations for hypoglycemia among older community-residing patients with type 2 diabetes who initiated long-acting insulin or NPH insulin in real-world settings.

View Article and Find Full Text PDF

Objective: To assess whether initiation of insulin glargine (glargine), compared with initiation of NPH or insulin detemir (detemir), was associated with an increased risk of breast cancer in women with diabetes.

Research Design And Methods: This was a retrospective new-user cohort study of female Medicare beneficiaries aged ≥65 years initiating glargine (203,159), detemir (67,012), or NPH (47,388) from September 2006 to September 2015, with follow-up through May 2017. Weighted Cox proportional hazards regression was used to estimate hazard ratios (HRs) and 95% CIs for incidence of breast cancer according to ever use, cumulative duration of use, cumulative dose of insulin, length of follow-up time, and a combination of dose and length of follow-up time.

View Article and Find Full Text PDF

The goal of this research was to assess patterns of beverage consumption and the contribution of total beverages and classes of beverages to overall energy intake and weight status. We conducted an analysis in a community-based study of 280 low-income overweight and obese African American women residing in the rural South. Participants provided baseline data including demographic characteristics, weight and two 24-h food and beverage dietary recalls.

View Article and Find Full Text PDF